Motion Sickness
📧 Sign up to get email alerts when something new happens for Motion Sickness.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-03-01FDA Approved: TRANSDERM SCOP — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Transderm Scop (scopolamine) by Baxter Healthcare Corporation, updating the product's approv…
-
FDA approval · 2018-12-12FDA Approved: MECLIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Meclizine hydrochloride from Rising Pharma Holdings, Inc. The action updates the product lab…
-
FDA approval · 2018-08-22FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Armas Pharmaceuticals Inc.)
FDA approved the original generic application for diphenhydramine hydrochloride from Armas Pharmaceuticals, making a generic diphenhydramine…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. [Phase 1]
A Phase 1 trial comparing a new scopolamine transdermal patch to the reference patch in healthy adults to evaluate bioavailability and adhes…
-
FDA approval · 2018-04-13FDA Approved: MECLIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Meclizine Hydrochloride from Rising Pharma Holdings, Inc., authorizing changes related to the pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray [Phase 2, Phase 3]
Phase 2/3 trial of intranasal scopolamine spray for motion sickness was terminated; results posted in 2018.
-
FDA approval · 2017-09-13FDA Approved: TRANSDERM SCOP — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for Transderm Scop (scopolamine) from Baxter Healthcare Corporation.
-
FDA approval · 2017-07-17FDA Approved: TRANSDERM SCOP — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for TRANSDERM SCOP (scopolamine) from Baxter Healthcare Corporation. This action updates the lab…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers [NA]
A completed clinical trial evaluated transcutaneous vagal nerve stimulation for reducing visually induced motion sickness in healthy volunte…
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Levo Phencynonate Hydrochloride for the Prevention of Seasickness [Phase 2]
Phase 2 trial evaluating Levo Phencynonate Hydrochloride for the prevention of seasickness has been completed.
-
FDA approval · 2015-01-30FDA Approved: SCOPOLAMINE TRANSDERMAL SYSTEM — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Scopolamine Transdermal System from Padagis Israel Pharmaceuticals Ltd under an original application (ANDA 078830) for the prev…
-
FDA approval · 2013-08-15FDA Approved: MECLIZINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for Meclizine Hydrochloride (meclizine), a generic antihistamine used to …
-
FDA approval · 2012-12-30FDA Approved: PROMETHEGAN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Cosette Pharmaceuticals' PROMETHEGAN (promethazine hydrochloride), updating its labeling und…
-
FDA approval · 2012-12-28FDA Approved: MECLIZINE HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for Meclizine Hydrochloride by Epic Pharma LLC.
-
FDA label_change · 2012-10-23FDA Approved: MECLIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for meclizine hydrochloride filed by Rising Pharma Holdings, resulting in changes to the product lab…
-
FDA approval · 2012-09-17FDA Approved: MECLIZINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Meclizine Hydrochloride as a generic drug under Original Application (ANDA 202640). The approval pro…
-
FDA approval · 2012-06-28FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
The FDA approved Promethazine hydrochloride as an original generic drug application (ANDA) for Cranbury Pharmaceuticals, LLC.
-
FDA approval · 2012-04-13FDA Approved: MECLIZINE HYDROCHLORIDE — Original Application (Epic Pharma LLC)
FDA approves Epic Pharma LLC's original application for Meclizine hydrochloride. This generic drug is used for motion sickness and vertigo.
-
FDA approval · 2011-02-23FDA Approved: MECLIZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original ANDA for meclizine hydrochloride tablets, a generic medication for motion sickness and ve…
-
FDA approval · 2010-12-13FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' original application for generic promethazine hydrochloride, enabling the sale of a generic antihis…
-
FDA approval · 2010-06-04FDA Approved: MECLIZINE HYDROCHLORIDE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for meclizine hydrochloride from Jubilant Cadista Pharmaceuticals Inc., enabling a generic version of …
-
FDA approval · 2009-06-10FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for diphenhydramine hydrochloride (PAI Pharma) under an ANDA.
-
FDA approval · 2008-12-18FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for prochlorperazine maleate from Jubilant Cadista Pharmaceuticals Inc., updating the labeling for t…
-
FDA approval · 2008-04-24FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (XGen Pharmaceuticals DJB, Inc.)
The FDA approved the original ANDA for Promethazine hydrochloride (Promethazine HCl) from XGen Pharmaceuticals DJB, Inc. The approval covers…
-
CLINICAL_TRIALS trial_result · 2007-04-09Clinical Trial Update: Effects of Transdermal Scopolamine on Occupational Performance [Phase 2]
Phase 2 clinical trial evaluating transdermal scopolamine for improving occupational performance in motion sickness; study status completed.